These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
605 related articles for article (PubMed ID: 33850477)
1. Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap. Shi B; Ding J; Qi J; Gu Z Int J Med Sci; 2021; 18(9):2063-2075. PubMed ID: 33850477 [TBL] [Abstract][Full Text] [Related]
2. DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma. Li P; Liu J; Li J; Liu P Mol Biol Rep; 2019 Aug; 46(4):4377-4383. PubMed ID: 31147860 [TBL] [Abstract][Full Text] [Related]
3. ERBB2 is a potential diagnostic and prognostic biomarker in renal clear cell carcinoma. Gao WN; Chen LG; Bao LR; He N; Hu TL; Lai C; Xu RF; Wang XF; Wang JY; Zhao JR; Meng Y Sci Rep; 2024 Oct; 14(1):22775. PubMed ID: 39353993 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma. Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of KLFs family genes in renal clear cell carcinoma. Fu M; Du Y; Liu F; Xiao J; Zhang L; Zeng Y; Yang Y; Yan Y Sci Rep; 2024 Aug; 14(1):20204. PubMed ID: 39215019 [TBL] [Abstract][Full Text] [Related]
6. Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell Carcinoma. Zhang D; Wang Y; Hu X DNA Cell Biol; 2020 Oct; 39(10):1799-1812. PubMed ID: 32716214 [TBL] [Abstract][Full Text] [Related]
7. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607 [TBL] [Abstract][Full Text] [Related]
8. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity. Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484 [TBL] [Abstract][Full Text] [Related]
9. Identification of transforming growth factor beta induced (TGFBI) as an immune-related prognostic factor in clear cell renal cell carcinoma (ccRCC). Du GW; Yan X; Chen Z; Zhang RJ; Tuoheti K; Bai XJ; Wu HH; Liu TZ Aging (Albany NY); 2020 May; 12(9):8484-8505. PubMed ID: 32406866 [TBL] [Abstract][Full Text] [Related]
10. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma. Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma. Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694 [TBL] [Abstract][Full Text] [Related]
12. Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma. Tang W; Cao Y; Ma X Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633782 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker. Zhang D; Liang P; Xia B; Wu J; Hu X BMC Cancer; 2024 Aug; 24(1):987. PubMed ID: 39123194 [TBL] [Abstract][Full Text] [Related]
14. An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma. Wu Y; Wei X; Feng H; Hu B; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Wang S; Liu J; Wang T Aging (Albany NY); 2020 Nov; 12(22):23165-23186. PubMed ID: 33221754 [TBL] [Abstract][Full Text] [Related]
15. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma. Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803 [TBL] [Abstract][Full Text] [Related]
16. TUBA1C orchestrates the immunosuppressive tumor microenvironment and resistance to immune checkpoint blockade in clear cell renal cell carcinoma. Li J; Chen M; Tong M; Cao Q Front Immunol; 2024; 15():1457691. PubMed ID: 39301023 [TBL] [Abstract][Full Text] [Related]
17. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma. Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of DNA Methylation-Driven Genes in Clear Cell Renal Cell Carcinoma: A Study Based on Methylation and Transcriptome Analyses. Hu M; Xie J; Hou H; Liu M; Wang J Dis Markers; 2020; 2020():8817652. PubMed ID: 32733620 [TBL] [Abstract][Full Text] [Related]
19. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma. Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma. Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]